-
Occupation of a thermoresistant-scaffold (alpha Rep) at SP1-NC cleavage site disturbs the function of HIV-1 protease
- Back
Metadata
Document Title
Occupation of a thermoresistant-scaffold (alpha Rep) at SP1-NC cleavage site disturbs the function of HIV-1 protease
Author
Hadpech S, Peerakam N, Chupradit K, Tayapiwatana C
Name from Authors Collection
Affiliations
Burapha University; Chiang Mai University; Chiang Mai University; Chiang Mai University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)
Type
Article
Source Title
BIOSCIENCE REPORTS
ISSN
0144-8463
Year
2020
Volume
40
Page
-
Open Access
Green Published, gold
Publisher
PORTLAND PRESS LTD
DOI
10.1042/BSR20201131
Format
Abstract
HIV-1 nucleocapsid (NC) becomes an attractive target for the development of novel anti-HIV-1 agents. Discovering of non-antibody scaffolds that disrupt the function of NC will be a potential aspect for disturbing viral maturation process. Correspondingly, we explored the specific binding site of the thermoresistant-scaffold protein, alpha Rep9A8 which formerly demonstrated the inhibitory effect on HIV-1 replication. The portion of Gag, CA(21)-SP1-NC has been used as a template for designing nine overlapping peptides (P4-P12). The P9 peptide showed the strongest binding activity followed by P8 and P12 respectively. The amino acid sequences on those peptides resemble the N-terminal domain of the NC proximity to the SP1-NC initial cleavage site and across the conserved CCHC zinc finger 1 (ZF1) of NC. The interaction K-D between alpha Rep9A8 with its target was 224.9 +/- 57.4 nM. Consequently, alpha Rep9A8 demonstrated the interference of the HIV-1 protease function by hindering a protease cleavage site. The released NC product from CA(21)-SP1-NC was diminished. The present study provided an additional information of alpha Rep9A8 function in interfering of viral maturation processes resulting in the decremental efficiency of viral infectivity.
Funding Sponsor
Faculty of Pharmaceutical Sciences [Rx11/2562]; Center of Biomolecular Therapy and Diagnostic (CBTD); Flagship Research Grant from National Research Council of Thailand [9576]; Biomedical Technology Research Center (BMTRC); Center of Excellence, Chiang Mai University; National Science and Technology Development Agency, Thailand; National Research and Innovation Council, Thailand
Publication Source
WOS